An experimental malaria vaccine GlaxoSmithKline PLC filed with regulators Thursday could help fight one of the worlds biggest killersbut rival company Sanaria Inc has a potentially more effective shot in the works If Europes regulators give Glaxos vaccinecalled RTSSthe green light it could be in use as soon as  paving the way for a mass vaccination program across subSaharan Africa That
  